Page 1 | Search Results | Blood | American Society of Hematology

1-7 of 7

Sort by

Sort Order Select

Journal Articles

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

Hiroyuki Muranushi, MD, Takero Shindo, MD PhD, Masakatsu Hishizawa, MD PhD, Masahito Tokunaga, MD PhD, Atsushi Wake, MD PhD, Nobuaki Nakano, MD, Tetsuya Eto, MD PhD, Michihiro Hidaka, MD PhD, Ilseung Choi, MD PhD, Toshihiro Miyamoto, MD PhD, Naoyuki Uchida, MD PhD, Yukiyoshi Moriuchi, MD, Yasuhiko Miyazaki, MD PhD, Takahiro Fukuda, Tatsuo Ichinohe, Yoshiko Atsuta, MD PhD, Koji Kato, MD PhD

Blood (2019) 134 (Supplement_1): 2008.

https://doi.org/10.1182/blood-2019-123318

Published: 2019

Journal Articles

The MEK Inhibitor Trametinib Enhances Diverse T Cell Reconstitution with Suppressing Xenogeneic Graft-Versus-Host-Disease

Hidekazu Itamura, MD PhD, Hiroyuki Muranushi, MD, Takero Shindo, MD PhD, Kazutaka Kitaura, DVM, PhD, Seiji Okada, MD PhD, Tadasu Shin-I, PhD, Ryuji Suzuki, DVM, PhD, Akifumi Takaori-Kondo, MD PhD, Shinya Kimura, MD PhD

Blood (2019) 134 (Supplement_1): 1929.

https://doi.org/10.1182/blood-2019-128913

Published: 2019

Journal Articles

Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

Takayuki Sato, MD PhD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Hiroyuki Sugiura, MD, Kazuya Okada, MD, Aki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 2539.

https://doi.org/10.1182/blood.V124.21.2539.2539

Published: 2014

Journal Articles

Absolute Lymphocyte Count As an Independent Prognostic Factor of IPI and NCCN-IPI in DLBCL Patients

Kazuya Okada, MD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Hiroyuki Sugiura, MD, Aki Sato, MD PhD, Takayuki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 1636.

https://doi.org/10.1182/blood.V124.21.1636.1636

Published: 2014

Journal Articles

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Yusuke Okamoto, MD, Shinichi Ochi, MD, Takashi Nagayama, MD, Shogo Nabe, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Hiroyuki Sugiura, MD, Kazuya Okada, MD, Aki Sato, MD PhD, Takayuki Sato, MD PhD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Yasunori Ueda, MD PhD

Blood (2014) 124 (21): 1654.

https://doi.org/10.1182/blood.V124.21.1654.1654

Published: 2014

Journal Articles

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

Tomoyasu Jo, MD, Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoaki Ueda, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 1528.

https://doi.org/10.1182/blood.V122.21.1528.1528

Published: 2013

Journal Articles

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Tomoaki Ueda, MD, Aki Sato, M.D., Kazuya Sakai, MD, Hiroyuki Muranushi, MD, Yusuke Okamoto, MD, Taku Tsukamoto, MD, Hiroyuki Sugiura, MD, Hiroyuki Matsui, MD, Tomoyasu Jo, MD, Kazuya Okada, MD, Takeshi Maeda, MD, Tatsuhito Onishi, MD, Akane Kunitomi, MD, PhD, Yasunori Ueda, MD, PhD

Blood (2013) 122 (21): 4551.

https://doi.org/10.1182/blood.V122.21.4551.4551

Published: 2013

NARROW

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

The MEK Inhibitor Trametinib Enhances Diverse T Cell Reconstitution with Suppressing Xenogeneic Graft-Versus-Host-Disease

Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

Absolute Lymphocyte Count As an Independent Prognostic Factor of IPI and NCCN-IPI in DLBCL Patients

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Email alerts

ASH Publications

American Society of Hematology

Graft-Versus-Host Disease-Free, Relapse-Free Survival in Allogeneic Stem Cell Transplantation for Adult T-Cell Leukemia/Lymphoma Provides a Novel Donor Selection Paradigm

The MEK Inhibitor Trametinib Enhances Diverse T Cell Reconstitution with Suppressing Xenogeneic Graft-Versus-Host-Disease

Clinical Significance of Risk Stratification Based on Disease Risk Index and Hematopoietic Cell Transplantation-Comorbidity Index

Absolute Lymphocyte Count As an Independent Prognostic Factor of IPI and NCCN-IPI in DLBCL Patients

SUV Max Reduction Criteria of Interim Positron Emission Tomography Improves Prognostic Value in Diffuse Large B-Cell Lymphoma: A Single-Center Retrospective Review

Pre-Treatment WT1 mRNA Expression Level In Peripheral Blood Predicts Response and Overall Survival Of Myelodysplastic Syndrome Patients In The Azacitidine Era

The Curative Potential Of Fludarabine125, Melphalan100, and Busulfan4 As a Conditioning Regimen For Myeloid Malignancies Of Elderly Patients

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only